A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

Candidate UTI vaccine low dose formulation 1OngoingRecruitingPhase 1Open NCT06702449 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT06702449 · Trial Tracker · ComplyRx